Table of Contents Table of Contents
Previous Page  119 / 364 Next Page
Information
Show Menu
Previous Page 119 / 364 Next Page
Page Background

4.1 CONSOLIDATED FINANCIAL STATEMENTS AND NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS

Note 10. Financing and financial security, net debt and cost of net debt

DANONE

REGISTRATION DOCUMENT 2015

119

Impairment review of the main brands with indefinite

useful lives

As of December 31, 2015, the Group reviewed the value of the

Nutri-

cia

and

Milupa

brands in accordance with the methodology and the

valuation model described above and on the basis of assumptions

based on those of the groups of CGUs concerned, while the

Dumex

brand was valued on the basis of the disposal agreement (see Note

6.2 of the Notes to the consolidated financial statements).

This review did not result in the recognition of any impairment

provisions.

In addition, analysis of the sensitivity of the value in use to the key

assumptions was carried out on each of these other main brands.

The key assumptions involved in the valuation model used by the

Group are (i) the growth in Net sales, (ii) the royalty rate, (iii) the

long-term growth rate used to calculate the terminal value, and

(iv) the discount rate. The following changes, deemed reasonably

possible, in the key assumptions do not alter the findings of the

impairment review,

i.e.

the absence of any impairment:

•

100 bps decrease in Net sales (decrease applied, each year, to

the assumptions concerning growth in Net sales, including the

final year, on the basis of the 2015 projections);

•

50 bps decrease in the royalty rate (decrease applied, each year,

to the assumptions concerning royalty rate, including the final

year, on the basis of the 2015 projections);

•

50 bps decrease in the long-term growth rate;

•

50 bps increase in the discount rate.

Other brands with indefinite useful lives

As of December 31, 2015, following the impairment review of the

other brands with indefinite useful lives, the Group recognized

impairment provisions on certain brands in the Fresh Dairy Products,

Waters and Early Life Nutrition Divisions in an aggregate amount

of €125 million, which was recorded under Other operating income

(expense) for the period.

As of December 31, 2014, following the impairment review of the

other brands with indefinite useful lives, the Group did not recognize

any impairment provision.

NOTE 10. FINANCING AND FINANCIAL SECURITY, NET DEBT AND COST

OF NET DEBT

Note 10.1. Accounting principles

Financing

Debt instruments are recognized in the consolidated balance sheet

(i) under the amortized cost method, using their effective interest

rate, or (ii) at their fair value.

When the fair value risk of a debt is hedged by a derivative, the change

in fair value of the hedged component of said debt is recognized in

the consolidated balance sheet, with the counterpart to the entry

being to the heading Other financial income (expense), which the-

reby offsets the change in fair value of the derivative instrument.

When future cash flows of a debt are hedged by a derivative, the

change in the fair value of the effective portion of the derivative

hedging said debt is recognized in the consolidated balance sheet,

with the counterpart to the entry being to consolidated equity, and

is recycled to profit or loss when the hedged item (the interest flows

relating to the hedged debt) impacts the consolidated net income.

Short-term investments

Short-term investments comprise marketable securities and other

short-term investments.

Marketable securities comprise highly liquid instruments with short

maturities that are easily convertible into a known amount of cash.

They aremeasured as securities held for trading within themeaning

of IAS 39, Financial Instruments: Recognition and Measurement and

are carried at their fair value.

Other short-term investments are measured at their fair value as

securities held for trading within the meaning of IAS 39, Financial

Instruments: Recognition and Measurement.

Changes in fair value of short-term investments are recognized

directly under the heading Interest income in the consolidated

income statement.

Translation of transactions denominated in foreign

currencies

At period-end, trade receivables and trade payables denominated in

foreign currencies are translated using exchange rates on that date.

Foreign exchange gains and losses arising from the translation of

borrowings or other instruments denominated in foreign currencies

that are used to hedge long-term investments denominated in the

same currencies are recognized in consolidated equity under the

heading Cumulative translation adjustments.

Note 10.2. Liquidity risk and management policy

Risk identification

Danone does not use debt in either a recurring or a significant way

in connection with its operating activities. Operating cash flows are

generally sufficient to finance the Group's business operations and

organic growth.

Danone may, however, take on additional debt to finance acquisi-

tions or, occasionally to manage its cash cycle, particularly when

dividends are paid to the Company's shareholders.

The Company's objective is always to keep this debt at a level enabling

it to maintain the flexibility of its financing sources.

Liquidity risk arises mainly from the maturities of its (i) interest-

bearing liabilities (bonds, bank debt, etc.), and (ii) non-interest-bea-

ring liabilities (liabilities on put options granted to non-controlling

interests), and from payments on derivative instruments.

As part of its debt management strategy, Danone regularly seeks

new financing to refinance its existing debt.